It was just ten months ago that Inflexion, the private equity group, took out a 40% stake in GlobalData’s healthcare business – in a £451m transformative deal that switched it into a net cash position.
At that time Mike Danson, the boss of GlobalData(LON:DATA), stated that the deal would give DATA the ability to pursue its own growth so much more aggressively either by organic or inorganic means.
The group’s shares were then 218p, before peaking at 230p and subsequently falling back precipitously to 128p at its lowest in early April this year.
But that was prior to events pro...
